You are here: Industry Insights > layoffs

News List

GSK forced to pay back £1.5m to Scottish Government after recent job cuts pharmafile
December 21, 2017
British pharmaceutical giant GlaxoSmithKline has been ordered to pay back £1.5 million to the Scottish Government because of its failure to keep its promises of a planned expansion.
Teva Announces Restructuring Plan, Cuts 25% of Workforce Worldwide americanpharmaceuticalreview
December 18, 2017
Teva Pharmaceutical announced a restructuring plan to significantly reduce its cost base, which includes laying off 14,000 employees worldwide.
Rumours have it that Teva job cut could be in the range of 10,000 pharmafile
December 12, 2017
Only last month, the story broke that Teva was looking to cut away a number of employees, the rumours have now intensified with reports suggesting the number could be in the region of 10,000.
79 Employees Affected as Novartis Plans Shut Down of UK Site biospace
December 06, 2017
Despite support for proposed government investment in the pharma and biotech industries in the United Kingdom, Novartis is looking to close down a facility in Sittingbourne, England that could cost about 79 jobs.
Teva Expected to Fire Up to 1,700 Workers in Israel, U.S biospace
November 28, 2017
Kåre Schultz, the new chief executive officer of Teva Pharmaceuticals will probably be likened to Dr. Seuss’ infamous character The Grinch as he reportedly plans to fire more than 1,000 employees this holiday season.
Teva looks set to axe thousands of positions and a big name pharmafile
November 24, 2017
Teva’s troubled year needs little detailing, those following the company have seen it lurch from one piece of bad news to another.
Life Science Giant PPD Cuts an Undisclosed Number of Jobs biospace
November 14, 2017
CRO giant Pharmaceutical Product Development, LLC has terminated a number of employees in its human resources department, but has provided few details about the job cuts, according to reports.
Novo Nordisk reducing 185 jobs while adding another 70 under pricing pressure fiercepharma
November 13, 2017
Still dealing with intense pricing pressure in its key diabetes business, Novo Nordisk has decided to cut 185 jobs in its commercial organization and add another 70, a spokesperson told FiercePharma.
Eli Lilly updated status for its 3500 job cuts plan fiercepharma
November 10, 2017
Eli Lilly has a status update for its massive round of job cuts aimed at saving $500 million per year: Around 2,300 employees have taken voluntary early retirements, and Lilly is "on track to achieve" the 3,500 cuts it laid out in September.
MSD cuts 1,800 jobs in US operations restructure pharmafile
October 24, 2017
MSD has revealed its intention to cut 1,800 sales positions from its workforce in the US.

Previous page 1 2 3 Next page